Artículos de revistas
Antileukotrienes In The Treatment Of Asthma And Allergic Rhinitis
Registro en:
Jornal De Pediatria. , v. 82, n. SUPPL. 2, p. S213 - S221, 2006.
217557
10.2223/JPED.1553
2-s2.0-33845731373
Autor
Ribeiro J.D.
Toro A.A.D.C.
Baracat E.C.E.
Institución
Resumen
Objective: To compare leukotriene antagonists (LTA) to other groups of drugs used in asthma and allergic rhinitis treatment. Sources: MEDLINE, LILACS and Cochrane Library. Keywords: leukotrienes, antileukotrienes, asthma treatment, allergic rhinitis treatment, asthma and allergic rhinitis. An attempt was made to group the main studies and reviews about this topic Summary of the findings: LTA are more efficient than placebo and enhance the effects of inhaled corticosteroids. The association of inhaled corticosteroids with long-acting β2 agonists is more efficient than the association of inhaled corticosteroids + LTA. Although use of LTA in acute asthma attacks and allergic rhinitis seems reasonable, more studies are needed to confirm this benefit. LTA reduce hospitalization time and the number of wheezing attacks in infants with acute viral bronchiolitis caused by respiratory syncytial virus, as well as recurrent wheezing after acute viral bronchiolitis. LTA are less efficient than intranasal corticosteroids for allergic rhinitis management. LTA are efficient in exercise-induced asthma, although they are not the first-line treatment. Conclusion: Controlled and randomized studies show that inhaled corticosteroids are the drugs of choice to treat persistent asthma and allergic rhinitis. There is not enough evidence to recommend the use of LTA as first-line drug (monotherapy) in children with asthma (level I). For children who cannot use inhaled corticosteroids, LTA may be a good alternative (level II). Copyright © 2006 by Sociedade Brasileira de Pediatria. 82 SUPPL. 2 S213 S221 Bisgaard, H., Szefler, S., Long-acting beta2 agonists and paediatric asthma (2006) Lancet, 367, pp. 286-288 (2005) Global Strategy for Asthma Management and Prevention NHLBI/WHO Workshop Report, , http://www.ginasthma.org/Guidelineitem.asp??l1=2&l2=1&intId=60, Updated Access: 17/09/2006 British guideline on the management of asthma (2003) Thorax, 58 (SUPPL. 1), pp. i1-94. , British Thoracic Society Scottish Intercollegiate Guidelines Network (1997) Guidelines for Diagnosis and Management of Asthma, , http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm, (NIH) National Asthma Education and Prevention Program. Publication No. 97-4051, Updated 2002. Access: 17/09/2006 Salpeter, S.R., Ormiston, T.M., Salpeter, E.E., Cardiovascular effects of β-agonists in patients with asthma and COPD: A metaanalysis (2004) Chest, 125, pp. 2309-2321 Bisgaard, H., Long-acting 2-agonists in management of childhood asthma: A critical review of the literature (2000) Pediatr Pulmonol, 29, pp. 221-234 Bisgaard, H., Effect of long-acting 2-agonists on exacerbation rates of asthma in children (2003) Pediatr Pulmonol, 36, pp. 391-398 Mann, M., Chowdhury, B., Sullivan, E., Nicklas, R., Anthracite, R., Meyer, R.J., Serious asthma exacerbations in asthmatics treated with high-dose formoterol (2003) Chest, 124, pp. 70-74 Wooltorton, E., Long-acting B2 agonists in asthma: Safety concerns (2005) CMAJ, 173, pp. 1030-1031 Nelson, H.S., Weiss, S.T., Bleecker, E.R., Yancey, S.W., Dorinsky, P.M., Is there a problem with inhaled long-acting b-adrenergic agonists? (2006) J Allergy Clin Immunol, 117, pp. 3-16. , SMART Study Group Nelson, H.S., Weiss, S.T., Bleecker, E.R., Yancey, S.W., Dorinsky, P.M., The salmeterol multicenter asthma research trial: A comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol (2006) Chest, 129, pp. 15-26. , SMART Study Group Martinez, F.D., Safety of long-acting beta-agonists - An urgent need to clear the air (2005) N Engl J Med, 353, pp. 2637-2639 Walia, M., Lodha, R., Kabra, S.K., Montelukast in pediatric asthma management (2006) Indian J Pediatr, 73, pp. 275-282 Langlois, A., Ferland, C., Tremblay, G.M., Laviolette, M., Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism (2006) J Allergy Clin Immunol, 118, pp. 113-119 Hay, D.W., Torphy, T.J., Undem, B.J., Cysteinyl leukotrienes in asthma: Old mediators up to new tricks (1995) Trends Pharmacol Sci, 16, pp. 304-309 Zeidler, M.R., Kleerup, E.C., Goldin, J.G., Kim, H.J., Truong, D.A., Simmons, M.D., Montelukast improves regional air-trapping. due to small airways obstruction in asthma (2006) Eur Respir J, 27, pp. 307-315 Spahn, J.D., Covar, R.A., Jain, N., Gleason, M., Shimamoto, R., Szefler, S.J., Effect of montelukast on peripheral airflow obstruction in children with asthma (2006) Ann Allergy Asthma Immunol, 96, pp. 541-549 Nieto, A., Pamiesa, R., Olivera, F., Medinab, A., Caballeroa, L., Mazon, A., Montelukast improves pulmonary function measured by impulse oscillometry in children with asthma (Mio study) (2006) Respir Med, 100, pp. 1180-1185 Pizzichini, E., Leff, J.A., Reiss, T.F., Hendeles, L., Boulet, L.P., Wei, L.X., Montelukast reduces airway eosinophilic inflammation in asthma: A randomized, controlled trial (1999) Eur Respir J, 14, pp. 12-18 Laviolette, M., Malmstrom, K., Lu, S., Chervinsky, P., Pujet, J.C., Peszek, I., Montelukast added to inhaled beclomethasone in treatment of asthma (1999) Am J Respir Crit Care Med, 160, pp. 1862-1868. , Montelukast/Beclomethasone Additivity Group Lex, C., Zacharasiewicz, A., Payne, D.N., Wilson, N.M., Nicholson, A.G., Kharitonov, S.A., Exhaled breath condensate cysteinyl leukotrienes and airway remodeling in childhood asthma: A pilot study (2006) Respir Res, 7, p. 63 O'Shaughnessy, K.M., Wellings, R., Gillies, B., Fuller, R.W., Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion (1993) Am Rev Respir Dis, 147, pp. 1472-1476 Pavord, I.D., Ward, R., Woltmann, G., Wardlaw, A.J., Sheller, J.R., Dworski, R., Induced sputum eicosanoid concentrations in asthma (1999) Am J Respir Crit Care Med, 160, pp. 1905-1909 Straub, D.A., Moeller, A., Minocchieri, S., Hamacher, J., Sennhauser, F.H., Hall, G.L., The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma (2005) Eur Respir J, 25, pp. 289-294 Bisgaard, H., Zielen, S., Garcia-Garcia, M.L., Johnston, S.L., Gilles, L., Menten, J., Montelukast reduces asthma exacerbations in 2-to 5-year-old children with intermittent asthma (2005) Am J Respir Crit Care Med, 171, pp. 315-322 Knorr, B., Franchi, L.M., Bisgaard, H., Vermeulen, J.H., Lesouef, P., Santanello, N., Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years (2001) Pediatrics, 108, pp. E48 Garcia, M.L., Wahn, U., Gilles, L., Swern, A., Tozzi, C.A., Polos, P., Montelukast, compared with fluticasone, for control of asthma among 6- To 14-year-old patients with mild asthma: The MOSAIC study (2005) Pediatrics, 116, pp. 360-369 Ng, D., Salvio, F., Hicks, G., Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children (2004) Cochrane Database Syst Rev, (2), pp. CD002314 Ducharme, F.M., Di Salvio, F., Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children (Cochrane Review) (2004) The Cochrane Database of Systematic Reviews, (1). , Art. No.: CD002314. DOI:10.1002/14651858.CD002314 Szefler, S.J., Phillips, B.R., Martinez, F.D., Chinchilli, V.M., Lemanske, R.F., Strunk, R.C., Characterization of within-subject responses to fluticasone and montelukast in childhood asthma (2005) J Allergy Clin Immunol, 115, pp. 233-242 Zeiger, R.S., Szefler, S.J., Phillips, B.R., Schatz, M., Martinez, F.D., Chinchilli, V.M., Childhood asthma research and education network of the National Heart, Lung, and Blood Institute. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma (2006) J Allergy Clin Immunol, 117, pp. 45-52 Vaquerizo, M.J., Casan, P., Castillo, P., Perpina, P., Sanchis, J., Sobradillo, V., Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma (2003) Thorax, 58, pp. 204-210 Price, D.B., Hernandez, D., Magyar, P., Fiterman, J., Beeh, K.M., James, I.G., Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma (2003) Thorax, 58, pp. 211-216 Ducharme, F., Schwartz, Z., Hicks, G., Kakuma, R., Addition of antileukotriene agents to inhaled corticosteroids for chronic asthma (2004) Cochrane Database Syst Rev, (2), pp. CD003133 Bjermer, L., Bisgaard, H., Bousquet, J., M Fabbri, L.M., Greening, A.P., Haahtela, T., Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: One year, double blind, randomised, comparative trial (2003) BMJ, 327, pp. 891-897 Bjermer, L., Bisgaard, H., Bousquet, J., Fabbri, L.M., Greening, A., Haahtela, T., Montelukast or salmeterol combined with an inhaled steroid in adult asthma: Design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial) (2000) Respir Med, 94, pp. 612-621 Ringdal, N., Eliraz, A., Pruzinec, R., Weber, H.H., Mulder, P.G., Akveld, M., The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma (2003) Respir Med, 97, pp. 234-241 Ram, F.S., Cates, C.J., Ducharme, F.M., Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma (2005) Cochrane Database Syst Rev, 25, pp. CD003137 Harmanci, K., Bakirtas, A., Turktas, I., Degim, T., Oral montelukast treatment of preschool-aged children with acute asthma (2006) Ann Allergy Asthma Immunol, 96, pp. 731-735 Rodrigo, G.J., Yañez, A., The role of antileukotriene therapy in seasonal allergic rhinitis: A systematic review of randomized trials (2006) Ann Allergy Asthma Immunol, 96, pp. 779-786 Peters-Golden, M., Henderson Jr., W.R., The role of leukotrienes in allergic rhinitis (2005) Ann Allergy Asthma Immunol, 94, pp. 609-618 Volovitz, B., Welliver, R.C., De Castro, G., Krystofik, D.A., Ogra, P.L., The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: Role in obstructive airway disease (1988) Pediatr Res, 24, pp. 504-507 Volovitz, B., Faden, H., Ogra, P.L., Release of leukotriene C4 in respiratory tract during acute viral infection (1988) J Pediatr, 112, pp. 218-222 Van Schaik, S.M., Tristram, D.A., Nagpal, I.S., Hintz, K.M., Welliver II, R.C., Welliver, R.C., Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing (1999) J Allergy Clin Immunol, 103, pp. 630-636 Bisgaard, H., A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis (2003) Am J Respir Crit Care Med, 167, pp. 379-383. , Study Group on Montelukast and Respiratory Syncytial Virus Wedde-Beer, K., Hu, C., Rodriguez, M.M., Piedimonte, G., Leukotrienes mediate neurogenic inflammation in lungs of young rats infected with respiratory syncytial virus (2002) Am J Physiol Lung Cell Mol Physiol, 282, pp. L1143-50 Harmanci, K., Bakirtas, A., Turktas, I., Degim, T., Oral montelukast treatment of preschool-aged children with acute asthma (2006) Ann Allergy Asthma Immunol, 96, pp. 731-735 Guilbert, T.W., Morgan, W.J., Zeiger, R.S., Mauger, D.T., Boehmer, S.J., Szefler, S.J., Long-term inhaled corticosteroids in preschool children at high risk for asthma (2006) N Engl J Med, 354, pp. 1985-1997 Becker, A.B., Kuznetsova, O., Vermeulen, J., Soto-Quiros, M.E., Young, B., Reiss, T.F., Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: A 56-week randomized double-blind study (2006) Ann Allergy Asthma Immunol, 96, pp. 800-807 Reiss, T.F., Hill, J.B., Harman, E., Zhang, J., Tanaka, W.K., Bronsky, E., Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist (1997) Thorax, 52, pp. 1030-1035 Peroni, D.G., Piacentini, G.L., Ress, M., Bodini, A., Loiacono, A., Aralla, R., Time efficacy of a single dose of montelukast on exercise-induced asthma in children (2002) Pediatr Allergy Immunol, 13, pp. 434-437 Pajaron-Fernandez, M., Garcia-Rubia, S., Sanchez-Solis, M., Garcia-Marcos, L., Montelukast administered in the morning or in the evening to prevent exercise induced bronchoconstriction in children (2006) Pediatric Pulmonol, 41, pp. 222-227 Melo, R.E., Sole, D., Naspitz, C.K., Exercise-induced bronchoconstriction in children: Montelukast attenuates the immediate phase and late phase responses (2003) J Allergy Clin Immunol, 111, pp. 301-317 De Benedictis, F.M., Del Giudice, M.M., Forenza, N., Decimo, F., De Benedictis, D., Capristo, A., Lack of tolerance to the protective effect of montelukast in exercise-induced bronchoconstriction in children (2006) Eur Respir J, 28, pp. 291-295 Green, J.J., Weinberg, E.G., Problems in the management of asthma in young children: A potential role for montelukast (2004) SAMJ, 94, pp. 746-748